| Induced pluripotent stem cells

Evotec
About Us
Careers
News
Resources
Blog
Events
Contact Us

Drug Design and Discovery
IND Enabling
- Integrated Development
- Capabilities
Integrated CMC
- Integrated Development
- Capabilities
INDiGO®
Evotec

Evotec and Celgene expand IPSC collaboration to include additional cell lines

by Nerina Coppini on Oct 11, 2018 8:05:42 AM

Tweet

$ 6 M payment to access additional cell lines

Topics: Corporate, Evotec, Celgene, IPSC, Induced pluripotent stem cells Read More

Posts by Topic

Corporate (51)
Evotec (23)
Drug Discovery (16)
Business (14)
Drug Development (12)
Drug design and discovery (9)
Partner Research Organization (8)
Sanofi (5)
Strategy (5)
Antibiotic Resistance (4)
Celgene (4)
INDiGO (4)
IPSC (4)
New appointments (4)
Acquisition (3)
Bayer (3)
CMC (2)
Contract Reseach Organization (2)
Endometriosis (2)
Gram-negative bacteria (2)
IND Enabling (2)
Integrated CMC (2)
NASH (2)
diabetes (2)
infectious diseases (2)
2018 results (1)
Active Pharmaceutical Ingredient (1)
Almirall (1)
Antibacterial (1)
Apeiron (1)
Aptuit (1)
Arix Bioscience (1)
Assay Development (1)
BRIDGE (1)
Blood cancer (1)
CENTOGENE (1)
CHDI (1)
CMO award (1)
Carna Biosciences (1)
Chronic cough (1)
Compound Logistics (1)
Computational Chemistry (1)
DDup (1)
Dementia Drug Discovery (1)
Dermatology (1)
Ferring (1)
Fibrosis (1)
Finance (1)
Form selection (1)
Fred Hutchinson Cancer Research Center (1)
Galapagos (1)
Haplogen (1)
Hit Discovery (1)
Huntington's disease (1)
Immuneering (1)
Induced pluripotent stem cells (1)
Integrated drug discovery (1)
Investments (1)
Kidney diseases (1)
LAB031 (1)
LEO Pharma (1)
Material Sciences (1)
Microbiome (1)
Novo Nordisk (1)
Obesity (1)
Oncology (1)
Parkinson's disease (1)
Phase I (1)
Regulatory (1)
Reproductive medicine (1)
Research collaboration (1)
Respiratory (1)
Retinal diseases (1)
Second Genome (1)
TARGETBCD (1)
Women's health (1)
Yumanity Therapeutics (1)
artificial intelligence (1)
beta cell replacement (1)
crispr (1)
first quarter update (1)
genomics (1)
hit identification (1)
immuno-oncology (1)
metabolic diseases (1)
microRNA (1)
pre-clinical development (1)
pulmonary diseases (1)
rare genetic diseases (1)
small molecule (1)
technology (1)

Legal
Privacy and cookies

Evotec and Celgene expand IPSC collaboration to include additional cell lines

Most Read

Posts by Topic

Connect With Us